FDA panel's recommendation

Strong recommendation: A Food and Drug Administration advisory committee voted 11-3 Monday to recommend the approval of over-the-counter sales of a prescription weight-loss pill.

Next step: A nonprescription version of GlaxoSmithKline's orlistat, a drug already marketed in prescription form as Xenical, still needs final FDA approval.

New ruling: The FDA has never approved any nonprescription weight-loss drugs for sale.